Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
|Brand name||Company Name||Status||Strength||Update||Date Updated||View Report|
|DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE||BAXTER CORPORATION||To be discontinued||392MG 2.5G 15.2MG 23.9MG 567MG||Updated Report||2020-01-23||91399|
|DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM||BAXTER CORPORATION||To be discontinued||448MG 1.5G 5.08MG 18.3MG 538MG||Updated Report||2020-01-23||91388|
|TEVA-DEFERASIROX||TEVA CANADA LIMITED||Discontinued||250MG||New Report||2020-01-21||103796|
|TEVA-DEFERASIROX||TEVA CANADA LIMITED||Discontinued||125MG||New Report||2020-01-21||103791|
|TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION||TEVA CANADA LIMITED||Discontinued||0.004%||New Report||2020-01-21||103788|